INDs & Case Reports

May 2020: ProMedica Hospital, Toledo, Ohio: 6 seriously ill COVID-19 patients with lung disease treated successfully under Expanded use IND approved by FDA:  https://www.dropbox.com/s/kkgz30ryjsetkp9/ProMedica%20Letter%20May11%2C%202020.pdf?dl=0

April 2020: Providence Center, Santa Monica, CA: 1 seriously ill COVID-19 patient with lung disease treated successfully under Emergency Use IND approved by FDA: http://www.stemedica.com/first-covid-19-patient-treated-under-emergency-use-ind-at-providence-saint-johns-health-center-using-stemedica-ischemia-tolerant-allogeneic-mesenchymal-bone-marrow-cells-2/

2010-2013: National Scientific Medical Center, Astana, Kazakhstan: Several patients treated with variety of neurological disorders with MSC and NSC with success.15 Patient Analysis from Kazakhstan itNSC & itMSC Treatments 

2001-2012: National Scientific Medical Center, Astana, Kazakhstan: Over 1,000 patients treated with MSC for Type 2 Diabetes Mellitus with success: Diabetes results in Kazakhstan itMSC Treatments